{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:15:36Z","timestamp":1760404536111},"reference-count":163,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.mehy.2013.10.029","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T17:32:08Z","timestamp":1384191128000},"page":"26-35","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autism\u2019s cancer connection: The anti-proliferation hypothesis and why it may matter"],"prefix":"10.1016","volume":"82","author":[{"given":"Charles S.","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.10.029_b0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1542\/peds.113.5.e472","article-title":"The genetics of autism","volume":"113","author":"Muhle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2013.10.029_b0010","first-page":"1","article-title":"Prevalence of autism spectrum disorders \u2013 autism and developmental disabilities monitoring network, 14 sites, United States, 2008","volume":"61","author":"C.D.C. Investigators","year":"2012","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.mehy.2013.10.029_b0015","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1542\/peds.2004-1958","article-title":"National autism prevalence trends from United States special education data","volume":"115","author":"Newschaffer","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2013.10.029_b0020","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ije\/dyp261","article-title":"Diagnostic change and the increased prevalence of autism","volume":"38","author":"King","year":"2009","journal-title":"Int J Epidem"},{"key":"10.1016\/j.mehy.2013.10.029_b0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/479022a","article-title":"The prevalence puzzle; autism counts","volume":"479","author":"Weintraub","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.10.029_b0030","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.285.24.3093","article-title":"Pervasive developmental disorders in preschool children","volume":"285","author":"Chakrabarti","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2013.10.029_b0035","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00004703-199810000-00001","article-title":"Outcomes of genetic evaluation in children with pervasive developmental disorder","volume":"19","author":"Chudley","year":"1998","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.mehy.2013.10.029_b0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0033291700028099","article-title":"Autism as a strongly genetic disorder: evidence from a British twin study","volume":"25","author":"Bailey","year":"1995","journal-title":"Psychol Med"},{"key":"10.1016\/j.mehy.2013.10.029_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.mp.4001896","article-title":"The genetics of autistic disorders and its clinical relevance: a review of the literature","volume":"12","author":"Freitag","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic heritability and shared environmental factors among twins with autism","volume":"68","author":"Hallmayer","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tics.2011.07.003","article-title":"Genetics of autism spectrum disorders","volume":"9","author":"Geschwind","year":"2011","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/j.mehy.2013.10.029_b0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature10945","article-title":"De novo mutations revealed by whole-exome sequencing are strongly associated with autism","volume":"485","author":"Sanders","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.10.029_b0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","article-title":"Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations","volume":"485","author":"O\u2019Roak","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.10.029_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11011","article-title":"Patterns and rates of exonic de novo mutations in autism spectrum disorders","volume":"484","author":"Neale","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.10.029_b0075","doi-asserted-by":"crossref","first-page":"e100255","DOI":"10.1371\/journal.pgen.1002556","article-title":"Networks of neuronal genes affected by common and rare variants in autism spectrum disorders","volume":"8","author":"Ben-David","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0080","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1126\/science.1138659","article-title":"Strong association of de novo copy number mutations with autism","volume":"316","author":"Sebat","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.mehy.2013.10.029_b0085","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajhg.2007.12.009","article-title":"Structural variation of chromosomes in autism spectrum disorders","volume":"82","author":"Marshall","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng.534","article-title":"A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay","volume":"42","author":"Girirajan","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0095","doi-asserted-by":"crossref","first-page":"e1002521","DOI":"10.1371\/journal.pgen.1002521","article-title":"Genetic and functional analysis of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders","volume":"8","author":"Leblond","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mp.2010.26","article-title":"A double hit implicates DIAPH3 as an autism risk gene","volume":"16","author":"Vorstman","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2006.05.010","article-title":"Searching for ways out of the autism maze: genetic, epigenetic, and environmental clues","volume":"29","author":"Persico","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/hmg\/ddl213","article-title":"Epigenetics of autism spectrum disorders","volume":"15","author":"Schanen","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0115","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.mehy.2013.10.029_b0120","first-page":"1","article-title":"Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promotor methylation","volume":"1","author":"Nargarajan","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.mehy.2013.10.029_b0125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1601-183X.2008.00414.x","article-title":"Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism","volume":"7","author":"Loat","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.mehy.2013.10.029_b0130","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YPG.0b013e32832cebd2","article-title":"Aberrations in folate metabolic pathway and altered susceptibility to autism","volume":"19","author":"Mohammad","year":"2009","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0135","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s10803-010-1120-x","article-title":"Population- and family-based studies associate the MTHFR gene with idiopathic autism in simplex families","volume":"41","author":"Lui","year":"2011","journal-title":"J Autism Dev Discord"},{"key":"10.1016\/j.mehy.2013.10.029_b0140","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1096\/fj.10-154484","article-title":"Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain","volume":"24","author":"Ngyen","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2013.10.029_b0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2012.14.3\/pchaste","article-title":"Autism risk factors: genes, environment, and gene-environment interactions","volume":"14","author":"Chaste","year":"2012","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1205707","article-title":"The immune response in autism: a new frontier for autism research","volume":"80","author":"Ashwood","year":"2006","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.mehy.2013.10.029_b0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargus","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2011.00027","article-title":"Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation","volume":"2","author":"Young","year":"2011","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0165","first-page":"S7","article-title":"NF-kB: tumour promoter or tumour suppressor?","volume":"91","author":"Perkins","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2013.10.029_b0170","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.mehy.2013.10.029_b0175","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1189\/jlb.0307166","article-title":"Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells","volume":"82","author":"Cools","year":"2007","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.mehy.2013.10.029_b0180","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.4049\/jimmunol.173.4.2353","article-title":"Initiation of immune responses in brain is promoted by local dendritic cells","volume":"174","author":"Karman","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2013.10.029_b0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0015-0282(99)00457-4","article-title":"The role of T-helper cytokines in human reproduction","volume":"73","author":"Lim","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.mehy.2013.10.029_b0190","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1128\/IAI.74.2.1106-1112.2006","article-title":"Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory","volume":"74","author":"Upham","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2013.10.029_b0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1289\/ehp.8566","article-title":"Perinatal immunotoxicity: why adult exposure assessment fails to predict risk","volume":"114","author":"Dietert","year":"2006","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.mehy.2013.10.029_b0200","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.earlhumdev.2004.10.017","article-title":"The influence of the mode of delivery on circulating cytokine concentration in the perinatal period","volume":"81","author":"Malamitsi-Puchner","year":"2005","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.mehy.2013.10.029_b0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1203\/01.PDR.0000157677.72136.09","article-title":"Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood","volume":"58","author":"Mainali","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0210","doi-asserted-by":"crossref","first-page":"e870","DOI":"10.1542\/peds.2007-2454","article-title":"Neonatal dexamethasone treatment for chronic lung disease of prematurity alters hypothalamus-pituitary-adrenal axis and immune system activity at school age","volume":"121","author":"Karemaker","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.mehy.2013.10.029_b0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/bjp.bp.108.051672","article-title":"Prenatal risk factors for autism: comprehensive meta-analysis","volume":"195","author":"Gardener","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/pr.56.1.5","article-title":"Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects","volume":"56","author":"Costa","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2013.10.029_b0225","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008","volume":"205","author":"Mitchell","year":"2011","journal-title":"AJOG"},{"key":"10.1016\/j.mehy.2013.10.029_b0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1469-8749.1994.tb11856.x","article-title":"Autism in thalidomide embryopathy: a population study","volume":"36","author":"Stromland","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0235","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/8466","article-title":"Free radical mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity","volume":"5","author":"Parman","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2013.10.029_b0240","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/annonc\/mdh300","article-title":"Thalidomide in cancer medicine","volume":"15","author":"Eleutherakis-Papaiakovou","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0245","first-page":"168","article-title":"Valproic acid embryopathy: a report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature","volume":"98","author":"Kozma","year":"2001","journal-title":"Med Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S0954579402003085","article-title":"Converging evidence of brain stem injury in autism","volume":"14","author":"Rodier","year":"2002","journal-title":"Dev Psychopathol"},{"key":"10.1016\/j.mehy.2013.10.029_b0255","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J Med Genetics"},{"key":"10.1016\/j.mehy.2013.10.029_b0260","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated with autistic disorder","volume":"47","author":"Rosalam","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0265","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2013.10.029_b0270","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2013.10.029_b0275","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2013.10.029_b0280","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0285","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.16.5.659","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"16","author":"Rasheed","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mehy.2013.10.029_b0290","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1093\/hmg\/ddi113","article-title":"Cancer epigenetics","volume":"14","author":"Laird","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0295","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/08830738050200110401","article-title":"\u03b22-Adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins","volume":"20","author":"Conners","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0300","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.103.060095","article-title":"Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex","volume":"308","author":"Rhodes","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2013.10.029_b0305","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.107.121483","article-title":"Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism","volume":"322","author":"Zerrate","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2013.10.029_b0310","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0006-2952(99)00064-7","article-title":"Synergistic effects of neurotensin and \u03b2-adrenergic agonist on 3\u2032,5\u2032-cyclic monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells","volume":"57","author":"Mitra","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2013.10.029_b0315","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1073\/pnas.95.5.2648","article-title":"Expression of Q227L-G\u03b1s in MCF-7 human breast cancer cells inhibits tumorigenesis","volume":"95","author":"Chen","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2013.10.029_b0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1006338232150","article-title":"\u03b2-Adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells","volume":"60","author":"Slotkin","year":"2000","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.mehy.2013.10.029_b0325","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"Croen","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0330","doi-asserted-by":"crossref","first-page":"f2059","DOI":"10.1136\/bmj.f2059","article-title":"Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based, case-control study","volume":"346","author":"Rai","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2013.10.029_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2013.00072","article-title":"Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior","volume":"7","author":"Kinast","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0340","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/bjc.1982.191","article-title":"Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas","volume":"46","author":"Tutton","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/j.mehy.2013.10.029_b0345","doi-asserted-by":"crossref","first-page":"e50043","DOI":"10.1371\/journal.pone.0050043","article-title":"Antiproliferative effects of fluoxetine on colon cancer cells and in colonic carcinogen mouse model","volume":"7","author":"Kannen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2013.10.029_b0350","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-09-4072","article-title":"The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.mehy.2013.10.029_b0355","first-page":"1043","article-title":"In vitro novel combination of psychotropics in anti-cancer modalities in U87 human glioblastoma cells","volume":"37","author":"Tzadok","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0360","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/10428190903552112","article-title":"The antidepressants maprotiline and fluoxetine have potent selective antiproliferation effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters","volume":"51","author":"Cloonan","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.mehy.2013.10.029_b0365","first-page":"277","article-title":"Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice","volume":"33","author":"Gil-Ad","year":"2008","journal-title":"Int J Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0370","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.bcp.2007.07.017","article-title":"Selective serotonin reuptake inhibitors-a new modality for treatment of lymphoma\/leukemia?","volume":"74","author":"Schuster","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2013.10.029_b0375","first-page":"23","article-title":"Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells","volume":"6","author":"Rosetti","year":"2006","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0380","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1096\/fj.04-3477fje","article-title":"The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics","volume":"19","author":"Meridith","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2013.10.029_b0385","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4161\/cbt.7.10.6664","article-title":"Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells","volume":"10","author":"Stepulak","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.mehy.2013.10.029_b0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/JMN:27:1:029","article-title":"Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines","volume":"27","author":"Levkovitz","year":"2005","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0395","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/mol.110.068122","article-title":"The tricyclic antidepressant amitriptyline inhibits d-cyclin tranactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence","volume":"79","author":"Mao","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2013.10.029_b0400","first-page":"88","article-title":"Defeating cancer with antidepressants","volume":"2","author":"Lieb","year":"2008","journal-title":"Ecancer"},{"key":"10.1016\/j.mehy.2013.10.029_b0405","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1038\/sj.mp.4001169","article-title":"Abnormal early brain development in autism","volume":"7","author":"Courchesne","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0410","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1523\/JNEUROSCI.1712-06.2006","article-title":"The developmental neurobiology of autism spectrum disorder","volume":"26","author":"DiCicco-Bloom","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0415","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/annonc\/mdh300","article-title":"Thalidomide in cancer medicine","volume":"15","author":"Eleutherakis-Papaiakovou","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0420","first-page":"644","article-title":"Secretion of tumor necrosis factor during fetal and neonatal development of mouse: ontogenic inflammation","volume":"8","author":"Yamasu","year":"1989","journal-title":"J Biol Response Mod"},{"key":"10.1016\/j.mehy.2013.10.029_b0425","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1095\/biolreprod54.3.554","article-title":"Tumor necrosis factors: pivotal components of preganacy?","volume":"54","author":"Hunt","year":"1996","journal-title":"Biol Reprod"},{"key":"10.1016\/j.mehy.2013.10.029_b0430","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1152\/ajpregu.1999.276.1.R59","article-title":"Induction of endogenous necrosis factor-alpha: suppression of centrally stimulated gastric motility","volume":"276","author":"Herman","year":"1999","journal-title":"Am J Regul Integr Comp Physiol"},{"key":"10.1016\/j.mehy.2013.10.029_b0435","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pediatrneurol.2007.01.012","article-title":"Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children","volume":"36","author":"Chez","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0440","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuroscience.2009.10.035","article-title":"Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects","volume":"165","author":"Sheikh","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2013.10.029_b0445","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2013.10.029_b0450","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2013.10.029_b0455","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/MCB.17.7.4015","article-title":"Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis","volume":"17","author":"Yoshida","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.mehy.2013.10.029_b0460","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2006.06.017","article-title":"Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations","volume":"142","author":"Hallene","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2013.10.029_b0465","doi-asserted-by":"crossref","first-page":"e19488","DOI":"10.1371\/journal.pone.0019488","article-title":"A study of nuclear transcription factor-kappa B in childhood autism","volume":"6","author":"Naik","year":"2011","journal-title":"PLos One"},{"key":"10.1016\/j.mehy.2013.10.029_b0470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/0707-MR-196","article-title":"Nuclear factor-B activation: from bench to bedside","volume":"233","author":"Sethi","year":"2008","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.mehy.2013.10.029_b0475","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/8466","article-title":"Free radical mediated oxidative DNA damage mechanism of thalidomide teratogenicity","volume":"5","author":"Parman","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2013.10.029_b0480","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfn263","article-title":"Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental defecits, and cancer","volume":"108","author":"Wells","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.mehy.2013.10.029_b0485","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.pharmtox.42.083001.110955","article-title":"Molecular basis of environmentally induced birth defects","volume":"42","author":"Finnell","year":"2002","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2013.10.029_b0490","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(00)00013-9","article-title":"Mechanisms of action of valproate: a commentary","volume":"37","author":"Johannessen","year":"2000","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mehy.2013.10.029_b0495","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s004410100356","article-title":"GABA signaling during development: new data and old questions","volume":"305","author":"Varju","year":"2001","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0500","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0006-2952(01)00696-7","article-title":"Neurotransmitters and apoptosis in the developing brain","volume":"62","author":"Ikonomidou","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2013.10.029_b0505","first-page":"PR1","article-title":"Elevated plasma gamma-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism","volume":"8","author":"Dhossche","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.mehy.2013.10.029_b0510","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.bi.64.070195.001221","article-title":"The roles of retinoids in vertebrate development","volume":"64","author":"Means","year":"1995","journal-title":"Ann Rev Biochem"},{"key":"10.1016\/j.mehy.2013.10.029_b0515","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0959-437X(00)00100-3","article-title":"Retinoid signaling and hindbrain patterning","volume":"10","author":"Gavalas","year":"2000","journal-title":"Curr Opi Genet Dev"},{"key":"10.1016\/j.mehy.2013.10.029_b0520","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ntt.2006.08.004","article-title":"Induction of the homeotic gene Hoxa1 through valproic acid\u2019s teratogenic mechanism of action","volume":"28","author":"Stogell","year":"2006","journal-title":"Neuotoxicol Teratol"},{"key":"10.1016\/j.mehy.2013.10.029_b0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1471-4159.2002.01081.x","article-title":"Antiproliferative action of valproate associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase","volume":"83","author":"Bacon","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.mehy.2013.10.029_b0530","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<284::AID-TERA3>3.0.CO;2-Z","article-title":"Valproic acid-induced changes in gene expression during neuralation in a mouse model","volume":"54","author":"Wlodarczyk","year":"1996","journal-title":"Teratology"},{"key":"10.1016\/j.mehy.2013.10.029_b0535","first-page":"1410","article-title":"Thalidomide induces limb deformities by perturbing Bmp\/Dkk1\/Wnt signaling path","volume":"21","author":"Knobloch","year":"2007","journal-title":"J Fed Am Soc Exp Biol"},{"key":"10.1016\/j.mehy.2013.10.029_b0540","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-04-019711","article-title":"Histone deacetylase activities are required for innate immune cell control of TH1 but not TH2 effector cell function","volume":"109","author":"Brogdon","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2013.10.029_b0545","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-06-2903","article-title":"Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity","volume":"13","author":"Nencioni","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0550","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/mol.65.3.520","article-title":"Valproic acid inhibits angiogenesis in vitro and in vivo","volume":"65","author":"Michaelis","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2013.10.029_b0555","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijdevneu.2004.05.004","article-title":"Maternal administration of thalidomide and valproic acid causes abnormal serotonergic neurons in offspring: implication for autism pathogenesis","volume":"23","author":"Miyazaki","year":"2005","journal-title":"Intl J Dev Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0560","first-page":"576","article-title":"Increased monamine concentration in the brain and blood of fetal thalidomide-and valproic acid-exposed rat: putative animal models for autism","volume":"52","author":"Narita","year":"2002","journal-title":"Pediatr Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0565","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neures.2009.09.001","article-title":"Nonexploratory movement and behavioral alterations in thalidomide or valproic acid-induced autism model rat","volume":"66","author":"Narita","year":"2010","journal-title":"Neurosci Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0570","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1469-7610.1987.tb00677.x","article-title":"Whole blood serotonin in autistic and normal subjects","volume":"28","author":"Anderson","year":"1987","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0575","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9","article-title":"Developmental changes in serotonin synthesis capacity in autistic and nonautistic children","volume":"45","author":"Chugani","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0580","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07357900600814979","article-title":"Deacetylase inhibitors in cancer therapy","volume":"24","author":"Fouladi","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.mehy.2013.10.029_b0585","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1158\/1078-0432.CCR-08-2787","article-title":"Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical complications","volume":"15","author":"Schrump","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0590","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-8722-3-5","article-title":"Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents","volume":"3","author":"Tan","year":"2010","journal-title":"J Hem Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0595","doi-asserted-by":"crossref","first-page":"R138","DOI":"10.1093\/hmg\/ddl213","article-title":"Epigenetics of autism spectrum disorders","volume":"15","author":"Schanen","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mehy.2013.10.029_b0600","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1523\/JNEUROSCI.0097-09.2009","article-title":"Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function","volume":"29","author":"Akhtar","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0605","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/30764","article-title":"Transcriptional repression by methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex","volume":"393","author":"Nan","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2013.10.029_b0610","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","article-title":"MeCP2 controls excitatory synaptic strength by regulating synapse number","volume":"56","author":"Chao","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2013.10.029_b0615","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.mehy.2013.10.029_b0620","first-page":"7093","article-title":"Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy","volume":"50","author":"Cho-Chung","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0625","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2002.tb04332.x","article-title":"Protein kinase A as target for novel integrated strategies of cancer therapy","volume":"968","author":"Tortora","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2013.10.029_b0630","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/07357908909038282","article-title":"Basic science review: site-selective cyclic AMP analogs as new biological tools in growth control, differentiation and proto-oncogene regulation","volume":"7","author":"Cho-Chung","year":"1989","journal-title":"Cancer Invest"},{"key":"10.1016\/j.mehy.2013.10.029_b0635","first-page":"1682","article-title":"Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal and immunological effects","volume":"5","author":"Propper","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.048421","article-title":"Ontogenesis of adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs","volume":"306","author":"Slotkin","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2013.10.029_b0645","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(02)00925-5","article-title":"Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver","volume":"59","author":"Garofolo","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.mehy.2013.10.029_b0650","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.4049\/jimmunol.0903066","article-title":"Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells","volume":"185","author":"Garay","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2013.10.029_b0655","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11689-011-9093-4","article-title":"Prenatal exposure to 2-adrenergic receptor agonists and risk of autism spectrum disorders","volume":"3","author":"Croen","year":"2011","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.mehy.2013.10.029_b0660","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1007\/s00406-009-0061-x","article-title":"The role of ceramide in major depressive disorder","volume":"259","author":"Kornhuber","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0665","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1176\/jnp.5.3.322","article-title":"Human brain fluoxetine concentrations","volume":"5","author":"Karson","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0670","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2013.10.029_b0675","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/jpet.111.183855","article-title":"Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero of via breast milk","volume":"339","author":"Capello","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2013.10.029_b0680","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.juro.2008.07.034","article-title":"Damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors using semen analysis and sperm chromatin structure assay","volume":"180","author":"Safarinejad","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.mehy.2013.10.029_b0685","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/humrep\/des383","article-title":"The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond","volume":"28","author":"Domar","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.mehy.2013.10.029_b0690","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0361-9230(01)00614-1","article-title":"Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation, and apoptosis","volume":"56","author":"Azmitia","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.mehy.2013.10.029_b0695","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijdevneu.2004.07.022","article-title":"Behavioral and cellular consequences of increasing serotonergic activity during brain development: role in autism?","volume":"23","author":"Whitaker-Azmita","year":"2005","journal-title":"Int J Devel Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0700","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1469-8749.2008.03027.x","article-title":"Serotonin and dopamine transporter binding in children with autism determined by SPECT","volume":"50","author":"Makkonen","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.mehy.2013.10.029_b0705","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuropharm.2011.02.002","article-title":"Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors","volume":"60","author":"Azmitia","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2013.10.029_b0710","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/030089168507100608","article-title":"Cancer therapy: phenothiazines in an unexpected role","volume":"71","author":"Jones","year":"1985","journal-title":"Tumori"},{"key":"10.1016\/j.mehy.2013.10.029_b0715","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.1986.4.6.994","article-title":"Calmodulin:a potential target of cancer chemotherapeutic agents","volume":"4","author":"Hait","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.mehy.2013.10.029_b0720","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:22:3:189","article-title":"Characterization of phenothiazine-induced apoptosis in neuroblastoma and glial cell lines: clinical relevance and possible application to brain-derived tumors","volume":"22","author":"Gil-Ad","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.mehy.2013.10.029_b0725","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/1535-7163.MCT-06-0402","article-title":"The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non-small cell lung carcinoma cells to DNA double-strand break-induced cell death","volume":"6","author":"Polischouk","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.mehy.2013.10.029_b0730","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","article-title":"Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer","volume":"186","author":"Yeh","year":"2012","journal-title":"Am J Respir Care Med"},{"key":"10.1016\/j.mehy.2013.10.029_b0735","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1158\/0008-5472.CAN-07-2235","article-title":"The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects via dual mitotic action","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0740","first-page":"3319","article-title":"Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodexyuridine followed by calmodulin inhibitors","volume":"48","author":"Lonn","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0745","first-page":"1101","article-title":"Preliminary studies of phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and colo 320 cells","volume":"19","author":"Pajak","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/j.mehy.2013.10.029_b0750","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00006842-199909000-00002","article-title":"History of modern psychopharmacology: a personal view with an emphasis on antidepressants","volume":"61","author":"Domino","year":"1999","journal-title":"Psychosom Med"},{"key":"10.1016\/j.mehy.2013.10.029_b0755","unstructured":"Physicians\u2019 Desk Reference. See Phenergan. (Thomson PDR) 2006; 3438\u20133440."},{"key":"10.1016\/j.mehy.2013.10.029_b0760","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1749-6632.1980.tb29621.x","article-title":"Pharmacological regulation of calmodulin","volume":"356","author":"Weiss","year":"1980","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2013.10.029_b0765","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.6203171","article-title":"Potentiation of bleomycin by anticalmodulin drugs: a role for calmodulin in DNA repair","volume":"224","author":"Chafouleas","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.mehy.2013.10.029_b0770","first-page":"1711","article-title":"Effect of anticalmodulin drugs on growth and sensitivity of C6 rat glioma cells to bleomycin","volume":"14","author":"Hait","year":"1994","journal-title":"Anticancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0775","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1968.48.1.155","article-title":"New approaches to the physiology of histamine","volume":"48","author":"Kahlson","year":"1968","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2013.10.029_b0780","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1126\/science.173.3993.247","article-title":"Nuclear localization of histamine in neonatal rat brain","volume":"173","author":"Young","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.mehy.2013.10.029_b0785","first-page":"4025","article-title":"Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels","volume":"47","author":"Brandes","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0790","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.0406776101","article-title":"Translationally controlled tumor protein is a target of tumor reversion","volume":"101","author":"Tuynder","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.mehy.2013.10.029_b0795","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuropharm.2005.10.005","article-title":"The human Ca2+-activated K+ channel, IK, can be blocked by the tricyclic antihistamine promethazine","volume":"50","author":"Wittekindt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2013.10.029_b0800","doi-asserted-by":"crossref","first-page":"325","DOI":"10.33549\/physiolres.930696","article-title":"Selective inhibition of brain Na K-ATPase by drugs","volume":"55","author":"Horvat","year":"2006","journal-title":"Physiol Res"},{"key":"10.1016\/j.mehy.2013.10.029_b0805","first-page":"459","article-title":"The effect of the antihistamine drugs on the central action of 5-hydroxytryptophan in mice","volume":"33","author":"Rogoz","year":"1981","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.mehy.2013.10.029_b0810","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/31.5.6841967","article-title":"Ultrastructural localization of phenothiazines and tetracyclin","volume":"31","author":"Hoff","year":"1983","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.mehy.2013.10.029_b0815","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/44.5.8627010","article-title":"Electron microscopic demonstration of intracellular promethazine accumulation sites by precipitation technique: application to cerebellar cortex of mouse","volume":"44","author":"Muller","year":"1996","journal-title":"J Histochem Cytochem"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771300515X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698771300515X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T10:44:01Z","timestamp":1688640241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698771300515X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":163,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S030698771300515X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.10.029","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autism\u2019s cancer connection: The anti-proliferation hypothesis and why it may matter","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}